Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2515-2522

  Brugts, Michael Pascal ^a   Van Den Beld, A W ^a   Hofland, L J ^a   Van Der Wansem, K ^a   Van Koetsveld, P M ^a   Frystyk, J ^b   Lamberts, S W J ^a   Janssen, J A M J L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

AGED; ARTICLE; BIOLOGICAL ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FOLLOW UP; HAZARD RATIO; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL; UNIVERSITY HOSPITAL;

ANIMALIA;

EID: 47549088668     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1633     Document Type: Article

References (29)

1. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
2. Kenyon C 2001 A conserved regulatory system for aging. Cell 105:165-168
3. Carter CS, Ramsey MM, Sonntag WE 2002 A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. Trends Genet 18:295-301
4. Barbieri M, Bonafe M, Franceschi C, Paolisso G 2003 Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol Endocrinol Metab 285:E1064-E1071
5. Lin K, Hsin H, Libina N, Kenyon C 2001 Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28:139-145
6. Bartke A 2005 Role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 146:3718-3723
7. Shimokawa I, Higami Y, Utsuyama M, Tuchiya T, Komatsu T, Chiba T, Yamaza H 2002 Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model. Am J Pathol 160:2259-2265
8. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, Even PC, Cervera P, Le Bouc Y 2003 IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421:182-187
9. Janssen JA, Lamberts SW 2004 Igf-I and longevity. Horm Res 62(Suppl 3):104-109
10. Collett-Solberg PF, Cohen P 2000 Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 12:121-136
11. Frystyk J 2004 Free insulin-like growth factors: measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 14:337-375
12. Clemmons DR 2001 Commercial assays available for insulin-like growth factor I and their use in diagnosing growth hormone deficiency. Horm Res 55(Suppl 2):73-79
13. Chen JW, Ledet T, Orskov H, Jessen N, Lund S, Whittaker J, De Meyts P, Larsen MB, Christiansen JS, Frystyk J 2003 A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 284:E1149-E1155
14. Sadick MD, Intintoli A, Quarmby V, McCoy A, Canova-Davis E, Ling V 1999 Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays. J Pharm Biomed Anal 19:883-891
15. Frystyk J 2007 Utility of free IGF-I measurements. Pituitary 10:181-187
16. Clemmons DR 2007 IGF-I assays: current assay methodologies and their limitations. Pituitary 10:121-128
17. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE 2003 Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157:25-31
18. Gotfredsen A, Jensen J, Borg J, Christiansen C 1986 Measurement of lean body mass and total body fat using dual photon absorptiometry. Metabolism 35:88-93
19. Blum WF, Breier BH 1994 Radioimmunoassays for IGFs and IGFBPs. Growth Regul 4(Suppl 1):11-19
20. de Ferranti SD, Rifai N 2007 C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol 16:14-21
21. Ridker PM, Hennekens CH, Buring JE, Rifai N 2000 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
22. Rincon M, Muzumdar R, Atzmon G, Barzilai N 2004 The paradox of the insulin/IGF-1 signaling pathway in longevity. Mech Ageing Dev 125:397-403
23. Stoving RK, Chen JW, Glintborg D, Brixen K, Flyvbjerg A, Horder K, Frystyk J 2007 Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. J Clin Endocrinol Metab 92:2323-2329
24. Rincon M, Rudin E, Barzilai N 2005 The insulin/IGF-1 signaling in mammals and its relevance to human longevity. Exp Gerontol 40:873-877
25. Andreassen M, Vestergaard H, Kristensen LO 2007 Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency. Clin Endocrinol (Oxf) 67:909-916
26. Jeschke MG, Barrow RE, Suzuki F, Rai J, Benjamin D, Herndon DN 2002 IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol Med 8:238-246
27. Sesmilo G, Fairfield WP, Katznelson L, Pulaski K, Freda PU, Bonert V, Dimaraki E, Stavrou S, Vance ML, Hayden D, Klibanski A 2002 Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. J Clin Endocrinol Metab 87:1692-1699
28. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ 2004 C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109:2058-2067
29. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, Bauersachs J 2007 Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 100:434-443